Geometry Dash APK Hill Climb Racing APK
47.2 F
New York
Wednesday, January 19, 2022

Is Zogenix (NASDAQ:ZGNX) Ready To Bounce After The Recent Correction?

Must read

Bombardier, Inc. (OTCMKTS:BDRBF) Continues to Gain Momentum and Strength

Many stocks have managed to record significant gains in recent months and one that often flies under the radar is Bombardier,...

Grayscale Bitcoin Trust (Btc) (GBTC) Makes Big Move As Bitcoin Goes Wild

Bitcoin, the world’s biggest cryptocurrency by market cap, has been in the middle of a remarkable rally for the past few months...

Voyager Digital Ltd (OTCMKTS:VYGVF) Hits All-Time High on Download News

The remarkable rally enjoyed by several crypto assets over the course of the past months has also resulted in an increased demand...

Solar Integrated Roofing Corp (OTCMKTS:SIRC) Surges Higher On Sector Strength

The Solar Integrated Roofing Corp (OTCMKTS:SIRC) stock has come into sharp focus among investors and on Wednesday, the stock made significant gains...

Stocks often bounce back even after going through a lot of pain for an extended period of time, and investors in pharmaceutical company Zogenix, Inc. (NASDAQ:ZGNX) must be hoping for such a recovery. It has declined by as much as 55% in the last three months, and the latest blow came about last month the U.S. Food and Drug Administration extended the review period for one of its products.

The product in question is Fintepla, for which the company had sent in a New Drug Application (NDA). However, it is important to figure out if the current price level of the stock presents a buying opportunity or not.

Dependent On Fintepla

Firstly, it should be noted that Zogenix does not have any approved products in the market at this point, and its fortunes are currently dependent on Fintepla. The medicine in question is meant to treat seizures suffered by Dravet syndrome patients. The medicine is being considered for other conditions as well, like Lennox-Gastaut syndrome (LGS).

However, the FDA stated that the NDA was not ‘sufficiently complete.’ The company, however, reiterated that it has high hopes for the product and is already preparing for its launch in Europe and the United States.

However, experts believe that even if Fintepla is eventually launched by the company, it will face stiff competition from companies like GW Pharmaceuticals. GW has made a success out of its CBD medicine Epidiolex and generated total sales of $296.4 million in 2019. Moreover, it has also emerged that Fintepla might not actually be particularly effective against a condition like Lennox-Gastaut syndrome.

Investors were not particularly moved from the Phase 3 data, which showed that seizures were reduced by only 26.5%. Hence, it is quite clear that the company is facing stiff competition for the only medicine that it has in the pipeline at the moment, and these factors make it a stock that could be avoided by investors at this point. Sign-up for continuing coverage on shares of $ZGNX stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $ZGNX, either long or short, and we have not been compensated for this article.

Latest article

iQSTEL Inc (OTCMKTS:IQST) Stock Makes a Big Move: Jumps 45% In a Week

In the past week, iQSTEL Inc (OTCMKTS: IQST) has emerged as a point of focus among a large number of investors and...

HUMBL Inc (OTCMKTS:HMBL) Stock Sees Big Bounce After Recent Slump

Since the beginning of 2021, HUMBL Inc (OTCMKTS:HMBL) had been one of the major movers from among penny stocks and had come into...

Dividend Stocks to Buy Now

A classic mistake that investors make when looking for dividend stocks is to just go for the biggest dividend yield. It makes...

88 Energy Ltd (OTCMKTS:EEENF) Stock Surges 40% But Can’t Hold Gains

The oil and gas company 88 Energy Ltd (OTCMKTS:EEENF) seems to have come back on to the radars of investors over the...

Net Savings Link Inc (OTCMKTS:NSAV) Stock is Getting Pummeled Again

Nowadays there are plenty of options for investors when it comes to making investments in the cryptocurrency and...
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet.
SmsVerifyer.com Affordable best sms verification service